Investing In The Biotechnology of Cannabis



Four world leaders in the clinical applications of cannabis take a deep dive into cannabinoid based drugs, IP, and the biotechnology of cannabis.

Panelists:
Matthew Callhan – Botanix Pharmaceuticals
Guy Chamberland – Tetra Bio-Pharma
John Docherty – Lexaria Biosciences
David Elsley – Cardiol Therapeutics
Moderated by Rahul Sarugaser – Paradigm Capital

Join us at an upcoming event! http://www.cambridgehouse.com

Be part of our investment community:
http://www.cambridgehouse.com/

https://www.facebook.com/cambridgehouseconferences
https://www.linkedin.com/company/cambridge-house-international/

Copyright © 2019 Cambridge House International Inc. All rights reserved.

source

%d bloggers like this: